300765 新诺威
已收盘 05-08 15:00:00
资讯
新帖
简况
新诺威(300765)披露2026年第二次临时股东大会通知,5月8日股价下跌0.16%
证券之星 · 05-08 22:20
新诺威(300765)披露2026年第二次临时股东大会通知,5月8日股价下跌0.16%
股市必读:4月30日新诺威发生1笔大宗交易 成交金额340.14万元
证券之星 · 05-06
股市必读:4月30日新诺威发生1笔大宗交易 成交金额340.14万元
每周股票复盘:新诺威(300765)一季报净利亏损9385万
证券之星 · 05-03
每周股票复盘:新诺威(300765)一季报净利亏损9385万
股市必读:新诺威一季报 - 第一季度单季净利润同比下降248.88%
证券之星 · 04-29
股市必读:新诺威一季报 - 第一季度单季净利润同比下降248.88%
股市必读:4月27日新诺威现1笔大宗交易 机构净卖出407.81万元
证券之星 · 04-28
股市必读:4月27日新诺威现1笔大宗交易 机构净卖出407.81万元
新诺威(300765.SZ)发布一季度业绩,归母净亏损9385.47万元,扩大248.88%
智通财经 · 04-27
新诺威(300765.SZ)发布一季度业绩,归母净亏损9385.47万元,扩大248.88%
新诺威:截至2026年4月10日股东数为21,973户
证券之星 · 04-23
新诺威:截至2026年4月10日股东数为21,973户
4月15日新诺威涨7.98%,工银前沿医疗股票A基金重仓该股
证券之星 · 04-15
4月15日新诺威涨7.98%,工银前沿医疗股票A基金重仓该股
新诺威(300765.SZ):SYS6051注射液获得药物临床试验批准
智通财经 · 04-15
新诺威(300765.SZ):SYS6051注射液获得药物临床试验批准
股市必读:新诺威(300765)4月7日董秘有最新回复
证券之星 · 04-08
股市必读:新诺威(300765)4月7日董秘有最新回复
新诺威:截至2026年3月31日,公司合并普通账户和融资融券信用账户股东数为24,034户
证券之星 · 04-07
新诺威:截至2026年3月31日,公司合并普通账户和融资融券信用账户股东数为24,034户
新诺威(300765)披露2025年度网上业绩说明会公告,4月03日股价下跌3.47%
证券之星 · 04-03
新诺威(300765)披露2025年度网上业绩说明会公告,4月03日股价下跌3.47%
4月1日新诺威涨8.47%,工银前沿医疗股票A基金重仓该股
证券之星 · 04-01
4月1日新诺威涨8.47%,工银前沿医疗股票A基金重仓该股
股市必读:新诺威(300765)3月27日董秘有最新回复
证券之星 · 03-30
股市必读:新诺威(300765)3月27日董秘有最新回复
新诺威:截至2026年3月20日股东数为21,269户
证券之星 · 03-28
新诺威:截至2026年3月20日股东数为21,269户
3月26日新诺威跌5.09%,工银前沿医疗股票A基金重仓该股
证券之星 · 03-26
3月26日新诺威跌5.09%,工银前沿医疗股票A基金重仓该股
股市必读:新诺威(300765)今年截至3月23日累计跌幅已超20%
证券之星 · 03-24
股市必读:新诺威(300765)今年截至3月23日累计跌幅已超20%
股市必读:新诺威(300765)3月18日披露最新机构调研信息
证券之星 · 03-19
股市必读:新诺威(300765)3月18日披露最新机构调研信息
新诺威:3月17日接受机构调研,包括知名机构淡水泉,高毅资产的多家机构参与
证券之星 · 03-18
新诺威:3月17日接受机构调研,包括知名机构淡水泉,高毅资产的多家机构参与
新诺威最新公告:2025年亏损2.41亿元同比由盈转亏
证券之星 · 03-16
新诺威最新公告:2025年亏损2.41亿元同比由盈转亏
加载更多
公司概况
公司名称:
石药创新制药股份有限公司
所属行业:
食品制造业
上市日期:
2019-03-22
主营业务:
石药创新制药股份有限公司的主营业务是生物制药、功能性原料及保健食品的研发、生产与商业化。公司的主要产品是恩朗苏拜单抗注射液、注射用奥马珠单抗注射液、咖啡因、阿卡波糖、果维康维生素C咀嚼片。公司是国内首批实现mRNA疫苗产业化、ADC与抗体药物管线布局最完整的创新型生物药企业之一,已发展成为集源头创新、临床转化、规模生产与国际商业化于一体的高新技术企业。
发行价格:
24.47
{"stockData":{"symbol":"300765","market":"SZ","secType":"STK","nameCN":"新诺威","latestPrice":32.07,"timestamp":1778223801000,"preClose":32.12,"halted":0,"volume":10086486,"delay":0,"changeRate":-0.0016,"floatShares":1405000000,"shares":1405000000,"eps":-0.2194,"marketStatus":"已收盘","change":-0.05,"latestTime":"05-08 15:00:00","open":32.12,"high":32.65,"low":31.23,"amount":323000000,"amplitude":0.0442,"askPrice":32.08,"askSize":52,"bidPrice":32.07,"bidSize":79,"shortable":0,"etf":0,"ttmEps":-0.2194,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":5,"adr":0,"adjPreClose":32.12,"symbolType":"stock","openAndCloseTimeList":[[1778203800000,1778211000000],[1778216400000,1778223600000]],"highLimit":35.33,"lowLimit":28.91,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1404592944,"isCdr":false,"pbRate":17.51,"roa":"--","roe":"--","epsLYR":-0.1731,"committee":-0.300423,"marketValue":45045000000,"turnoverRate":0.0072,"status":1,"floatMarketCap":45045000000},"requestUrl":"/m/hq/s/300765","defaultTab":"news","newsList":[{"id":"2633695457","title":"新诺威(300765)披露2026年第二次临时股东大会通知,5月8日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633695457","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633695457?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:20","pubTimestamp":1778250026,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,新诺威报收于32.07元,较前一交易日下跌0.16%,最新总市值为450.45亿元。新诺威于近日披露《关于召开2026年第二次临时股东会的提示性公告》。公告显示,公司将于2026年5月14日召开2026年第二次临时股东会,会议采用现场与网络投票相结合方式,股权登记日为2026年5月11日。其中,修订《公司章程》需经出席股东会的股东所持有效表决权股份总数的三分之二以上通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800043688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633928200","title":"股市必读:4月30日新诺威发生1笔大宗交易 成交金额340.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633928200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633928200?lang=zh_cn&edition=full","pubTime":"2026-05-06 02:53","pubTimestamp":1778007187,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,新诺威报收于30.37元,上涨1.44%,换手率0.84%,成交量11.77万手,成交额3.62亿元。交易信息汇总资金流向4月30日主力资金净流入1794.82万元,占总成交额4.96%;游资资金净流出485.23万元,占总成交额1.34%;散户资金净流出1309.59万元,占总成交额3.62%。大宗交易4月30日新诺威发生1笔大宗交易,成交金额340.14万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600000892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632742146","title":"每周股票复盘:新诺威(300765)一季报净利亏损9385万","url":"https://stock-news.laohu8.com/highlight/detail?id=2632742146","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632742146?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:31","pubTimestamp":1777750270,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,新诺威报收于30.37元,较上周的30.79元下跌1.36%。本周,新诺威4月27日盘中最高价报31.93元。本周关注点来自业绩披露要点:新诺威2026年一季报归母净利润-9385.47万元,同比下降248.88%。交易信息汇总4月30日新诺威发生1笔大宗交易,成交金额340.14万元。股本股东变化股东户数变动截至2026年4月20日,新诺威股东户数为2.29万户,较4月10日增加880.0户,增幅4.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631537603","title":"股市必读:新诺威一季报 - 第一季度单季净利润同比下降248.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537603","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631537603?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:56","pubTimestamp":1777416989,"startTime":"0","endTime":"0","summary":"来自业绩披露要点:新诺威2026年一季度归母净利润为-9385.47万元,同比下降248.88%。股本股东变化股东户数变动近日新诺威披露,截至2026年4月20日公司股东户数为2.29万户,较4月10日增加880.0户,增幅为4.0%。业绩披露要点财务报告新诺威2026年一季报显示,一季度公司主营收入6.65亿元,同比上升40.82%;归母净利润-9385.47万元,同比下降248.88%;扣非净利润-1.11亿元,同比下降262.55%;负债率57.0%,投资收益-505.0万元,财务费用2078.98万元,毛利率41.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900017166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630034391","title":"股市必读:4月27日新诺威现1笔大宗交易 机构净卖出407.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630034391","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630034391?lang=zh_cn&edition=full","pubTime":"2026-04-28 05:52","pubTimestamp":1777326770,"startTime":"0","endTime":"0","summary":"截至2026年4月27日收盘,新诺威报收于31.37元,上涨1.88%,换手率0.62%,成交量8.67万手,成交额2.69亿元。交易信息汇总资金流向4月27日主力资金净流出572.47万元;游资资金净流入141.28万元;散户资金净流入431.19万元。大宗交易4月27日新诺威现1笔大宗交易,机构净卖出407.81万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800015563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630313582","title":"新诺威(300765.SZ)发布一季度业绩,归母净亏损9385.47万元,扩大248.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630313582","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630313582?lang=zh_cn&edition=full","pubTime":"2026-04-27 23:15","pubTimestamp":1777302955,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新诺威(300765.SZ)发布2026年第一季度报告,该公司营业收入为6.65亿元,同比增长40.82%。归属于上市公司股东的净亏损为9385.47万元,同比扩大248.88%。归属于上市公司股东的扣除非经常性损益的净亏损为1.11亿元,同比扩大262.55%。基本每股亏损为0.0674元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434851.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"新诺威(300765.SZ)发布一季度业绩,归母净亏损9385.47万元,扩大248.88%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629878528","title":"新诺威:截至2026年4月10日股东数为21,973户","url":"https://stock-news.laohu8.com/highlight/detail?id=2629878528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629878528?lang=zh_cn&edition=full","pubTime":"2026-04-23 18:03","pubTimestamp":1776938586,"startTime":"0","endTime":"0","summary":"证券之星消息,新诺威(300765)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止4月10日股东人数是多少?新诺威回复:您好,感谢您对公司的关注,截至2026年4月10日,公司合并普通账户和融资融券信用账户股东数为21,973户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300049812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627040478","title":"4月15日新诺威涨7.98%,工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2627040478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627040478?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:13","pubTimestamp":1776240822,"startTime":"0","endTime":"0","summary":"证券之星消息,4月15日新诺威涨7.98%,收盘报33.97元,换手率1.61%,成交量22.62万手,成交额7.54亿元。重仓新诺威的前十大公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共38家,其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500028632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627106401","title":"新诺威(300765.SZ):SYS6051注射液获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2627106401","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627106401?lang=zh_cn&edition=full","pubTime":"2026-04-15 15:53","pubTimestamp":1776239592,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新诺威(300765.SZ)发布公告,公司的控股子公司石药集团巨石生物制药有限公司(以下简称“巨石生物”)于近日收到国家药品监督管理局核准签发关于SYS6051的《药物临床试验批准通知书》,将于近期开展临床试验。SYS6051是一款靶向人组织因子(Tissue Factor,TF)的抗体偶联药物,可与肿瘤细胞表面的组织因子结合,通过内吞作用进入细胞并释放毒素,达到杀伤肿瘤细胞的作用。本品按照治疗用生物制品1类申报。本次获批的适应症为晚期实体瘤。临床前研究显示,SYS6051对多种癌症均有较好的抗肿瘤作用,有望在后续临床试验中展现出良好的治疗效果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新诺威(300765.SZ):SYS6051注射液获得药物临床试验批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625950316","title":"股市必读:新诺威(300765)4月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625950316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625950316?lang=zh_cn&edition=full","pubTime":"2026-04-08 01:28","pubTimestamp":1775582893,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘,新诺威报收于33.25元,上涨2.28%,换手率0.77%,成交量10.84万手,成交额3.61亿元。董秘最新回复投资者: 请问贵公司截至2026年3月30日收盘的股东的户数?董秘: 您好,感谢您对公司的关注,截至2026年3月31日,公司合并普通账户和融资融券信用账户股东数为24,034户,谢谢!当日关注点来自交易信息汇总:4月7日主力资金净流出274.03万元,游资资金净流入3492.0万元,显示市场短期交易情绪分化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800000930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625818930","title":"新诺威:截至2026年3月31日,公司合并普通账户和融资融券信用账户股东数为24,034户","url":"https://stock-news.laohu8.com/highlight/detail?id=2625818930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625818930?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:54","pubTimestamp":1775562851,"startTime":"0","endTime":"0","summary":"证券之星消息,新诺威(300765)04月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截至2026年3月31日,公司最新股东数是多少?新诺威回复:您好,感谢您对公司的关注,截至2026年3月31日,公司合并普通账户和融资融券信用账户股东数为24,034户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700028419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624253659","title":"新诺威(300765)披露2025年度网上业绩说明会公告,4月03日股价下跌3.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624253659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624253659?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:45","pubTimestamp":1775209521,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,新诺威报收于32.51元,较前一交易日下跌3.47%,最新总市值为456.63亿元。该股当日开盘33.11元,最高33.52元,最低32.38元,成交额达3.44亿元,换手率为0.75%。公司于近日披露《关于举行2025年度网上业绩说明会的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595369","title":"4月1日新诺威涨8.47%,工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595369?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:18","pubTimestamp":1775031483,"startTime":"0","endTime":"0","summary":"证券之星消息,4月1日新诺威涨8.47%,收盘报34.45元,换手率1.62%,成交量22.75万手,成交额7.68亿元。重仓新诺威的前十大公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共38家,其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623956352","title":"股市必读:新诺威(300765)3月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2623956352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623956352?lang=zh_cn&edition=full","pubTime":"2026-03-30 01:00","pubTimestamp":1774803643,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘,新诺威报收于32.28元,上涨14.63%,换手率1.64%,成交量23.06万手,成交额7.14亿元。董秘最新回复投资者: 请问截止3月10日公司股东人数是多少?董秘: 您好,感谢您对公司的关注,截至2026年3月20日,公司合并普通账户和融资融券信用账户股东数为21,269户,谢谢!当日关注点来自交易信息汇总:3月27日主力资金净流入5580.28万元,呈现明显吸筹迹象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622802410","title":"新诺威:截至2026年3月20日股东数为21,269户","url":"https://stock-news.laohu8.com/highlight/detail?id=2622802410","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622802410?lang=zh_cn&edition=full","pubTime":"2026-03-28 10:48","pubTimestamp":1774666089,"startTime":"0","endTime":"0","summary":"证券之星消息,新诺威(300765)03月28日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好。请问贵公司截至2026年3月20日收盘的股东人数是多少?新诺威回复:您好,感谢您对公司的关注,截至2026年3月20日,公司合并普通账户和融资融券信用账户股东数为21,269户,谢谢!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800013874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622837941","title":"3月26日新诺威跌5.09%,工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622837941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622837941?lang=zh_cn&edition=full","pubTime":"2026-03-26 16:27","pubTimestamp":1774513665,"startTime":"0","endTime":"0","summary":"证券之星消息,3月26日新诺威跌5.09%,收盘报28.16元,换手率0.86%,成交量12.07万手,成交额3.47亿元。重仓新诺威的前十大公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共38家,其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600029066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","159891","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085982","title":"股市必读:新诺威(300765)今年截至3月23日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621085982?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:02","pubTimestamp":1774288941,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,新诺威报收于28.0元,下跌7.16%,换手率0.85%,成交量11.91万手,成交额3.43亿元。来自资金流向:3月23日主力资金净流出1454.49万元,散户资金净流入4562.21万元,呈现主力抛售、散户接盘态势。交易信息汇总股价提醒3月23日新诺威收盘报28元,跌7.16%,当日成交1190.93万元。该股已连续4日下跌,当年累计跌幅22.16%。前10个交易日资金流向显示:主力资金累计净流出2351.35万元,股价累计下跌9.22%;融资余额累计增加1188.84万元,融券余量累计增加4.34万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620266746","title":"股市必读:新诺威(300765)3月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620266746?lang=zh_cn&edition=full","pubTime":"2026-03-19 02:18","pubTimestamp":1773857893,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘,新诺威报收于32.05元,下跌0.93%,换手率0.54%,成交量7.56万手,成交额2.42亿元。当日关注点来自交易信息汇总:3月18日主力资金净流出153.66万元,散户资金净流入235.38万元。另外国内正在进行的 EGFR突变型肺癌3期临床试验已经完成入组,目前正在受试者随访中。的首个完整销售年度,公司生物制药业务收入实现显著增长。2026年,随着销售团队的持续扩充及市场推广力度的加大,公司看好生物制药业务的发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900001196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620528807","title":"新诺威:3月17日接受机构调研,包括知名机构淡水泉,高毅资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2620528807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620528807?lang=zh_cn&edition=full","pubTime":"2026-03-18 10:30","pubTimestamp":1773801034,"startTime":"0","endTime":"0","summary":"2026年以来,咖啡因价格趋于稳定,后续公司会持续关注咖啡因的价格走势。除上述临床外,公司也在积极推进食管鳞癌,乳腺癌等适应症。的首个完整销售年度,公司生物制药业务收入实现显著增长。2026年,随着销售团队的持续扩充及市场推广力度的加大,公司看好生物制药业务的发展。新诺威主营业务:生物制药和功能食品及原料的研发、生产和销售。该股最近90天内共有1家机构给出评级,买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800013153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619450921","title":"新诺威最新公告:2025年亏损2.41亿元同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2619450921","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619450921?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:40","pubTimestamp":1773661237,"startTime":"0","endTime":"0","summary":"新诺威发布2025年年度报告,2025年公司实现营业收入为21.58亿元,同比增长8.93%,归属于上市公司股东的净利润-2.41亿元,同比由盈转亏;基本每股收益-0.1731元。2025年公司投入研发费用10.36亿元,同比增长23.01%。公司在研项目众多,截至2025年末,公司拥有十余款处于临床或后期开发阶段的主要在研药物,其中乌司奴单抗注射液、帕妥珠单抗注射液已递交上市申请,多个项目处于关键临床试验阶段,这些研发成果将有望成为公司未来业绩增长的驱动引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600030714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778331439909,"stockEarnings":[{"period":"1week","weight":0.056},{"period":"1month","weight":-0.0534},{"period":"3month","weight":-0.0568},{"period":"6month","weight":0.021},{"period":"1year","weight":-0.1788},{"period":"ytd","weight":-0.1109}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"石药创新制药股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"22853人(较上一季度增加4.00%)","perCapita":"61462股","listingDate":"2019-03-22","address":"河北省石家庄市栾城区张举路62号","registeredCapital":"140459万元","survey":" 石药创新制药股份有限公司的主营业务是生物制药、功能性原料及保健食品的研发、生产与商业化。公司的主要产品是恩朗苏拜单抗注射液、注射用奥马珠单抗注射液、咖啡因、阿卡波糖、果维康维生素C咀嚼片。公司是国内首批实现mRNA疫苗产业化、ADC与抗体药物管线布局最完整的创新型生物药企业之一,已发展成为集源头创新、临床转化、规模生产与国际商业化于一体的高新技术企业。","listedPrice":24.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新诺威,300765,新诺威股票,新诺威股票老虎,新诺威股票老虎国际,新诺威行情,新诺威股票行情,新诺威股价,新诺威股市,新诺威股票价格,新诺威股票交易,新诺威股票购买,新诺威股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}